Malaria is the most common parasitic diseases affecting the largest number of people around the world followed by Schistosomar – or blood flukes, is an infectious parasite easily caught when the skin is in contact with contaminated water where the snails are living. it is not transmitted person to person.
People infected this parasite can infect other sources of clean water with their stools which contain the parasitic eggs. Shistosomiasis affects approximately 700 million people in over 70 countries in Africa, Asia and South America where it is very common. The parasite usually lives an average of 3 to 10 years but in rare cases even up to to 40 years. Schistosomar along with Leishmaniasis and Malaria have a big economic impact where the infection rate is high.
Initially, the person infected may show no apparent symptoms but within 2 months they may develop chills, fever, muscle aches and a cough.
If left untreated, the parasitic infection can lead to enlarged liver, abdominal pain, blood in urine and stools and problems urinating plus an increased risk in developing liver fibrosis and/or bladder cancer.
There is a drug called Praziquantel that is used to treat the Schistosoma worms and prevent them from growing and multiplying in the body.
Now the GOOD NEWS, a new study has been published in the International Immunopharmacology Journal, on Schistosoma and how the polysaccharides in the ABM mushroom can be used to treat or prevent this parasitic infection altogether.
The study showed that using the mushroom in a DOSE DEPENDENT and TIME DEPENDENT manner, it reduced the amount of worms and eggs and the infection rate. They used mice in this study as they also induced liver fibrosis in them. Using the mushrooms showed significant REDUCTION in fibrosis as well which is a very important finding.
This is a promising study on how strong the ABM mushrooms is and the effect this mushroom has on parasitic infections and against the formation of granulomas (cluster of immune cells that produce a mass).